Navigation Links
AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results
Date:8/12/2013

REDWOOD CITY, Calif., Aug. 12, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and six months ended June 30, 2013.

"With the successful completion of our Zalviso™ clinical program that includes data from all three Phase 3 studies, each of which met its primary endpoint, we are preparing to submit our New Drug Application (NDA), by the end of the third quarter," stated Richard King, president and CEO of AcelRx.  "We were pleased with the financing completed last month in which we raised almost $48 million in net proceeds.  This additional cash provides the resources to fund operations at least through the end of 2014 including commercial preparation activities for, and the potential launch of, Zalviso in the United States."

Second Quarter Financial ResultsNet loss for the second quarter of 2013 was $17.4 million, or $0.47 per share, compared with a net loss of $7.2 million, or $0.35 per share for the second quarter of 2012.  Adjusted net loss for the second quarter of 2013 was $8.1 million, or $0.22 per share and excludes the $9.3 million non-cash expense resulting from the liability accounting related to warrants issued in connection with the PIPE financing completed in June 2012. There was no such expense recorded in the second quarter of 2012.

During the second quarters of 2013 and 2012, AcelRx recognized revenue of $407,000 and $224,000, respectively, as reimbursement for work completed under a research grant from the U.S. Army Medical Research and Materiel Command (USAMRMC), for development of ARX-04, a sufentanil NanoTab pro
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
2. AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013
3. AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares
4. AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013
5. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
6. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
7. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
8. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
9. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
10. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
11. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... MIRAMAR BEACH, Fla. , June 30, 2015  July ... our country,s declaration of independence, and the spirit and people ... For Heroes Foundation has partnered with USA ... cards, to help increase funding for programs that empower independence ... across the country, and help more people afford their prescriptions. ...
(Date:6/30/2015)... 2015  Marken, the leading clinical trial logistics organization ... has been granted permission by the government to deliver ... product in Korea.  This precedent-setting shipment has allowed several ... continue receiving their clinical trial drugs during the outbreak ... emergency was caused by recent partial closures of medical ...
(Date:6/30/2015)... -- Legal-Bay LLC, the Lawsuit Settlement Funding Company, announced ... litigation (MDL) over the Zimmer NexGen Knee implant lawsuits ... 2015. There are currently more than a thousand cases ... federal judge in Illinois . The ... in October of this year. Zimmer Inc. previously issued ...
Breaking Medicine Technology:Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3
... ROCKVILLE, Md., Feb. 18, 2011 Novavax, Inc. ... today presented the final safety and immunogenicity results from ... clinical trial in Mexico at the invitation-only 7th World ... Vaccines in Clinical Trials. The meeting was held at ...
... Feb. 18, 2011 FUJIFILM Medical Systems ... footprint mobile application enabling remote access to ... as well as Macintosh- or Windows-based PCs.  Differentiated from ... quality, interactive three dimensional medical images in any platform ...
Cached Medicine Technology:NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 3NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 4NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 5Fujifilm's Synapse® Mobility Extends Imaging Reach 2
(Date:6/30/2015)... ... June 30, 2015 , ... As 1Heart Caregiver ... growth as a Master Franchisor. 1Heart Caregiver Services® welcomed its next Franchisee, 1Heart ... Commerce Ambassadors headed by Keith Mashburn, Pam Campeau, field representative of the California ...
(Date:6/30/2015)... ... July 01, 2015 , ... Popular ... easy to navigate. By making fundamental changes to the UI, the website hopes ... site said, “Finding the right website has been getting tougher. People are seeking ...
(Date:6/30/2015)... ... June 30, 2015 , ... Ticket Down announces that they have slashed prices across the ... Pantages Theatre. For the past 26 years, “The Phantom of the Opera” has ... musical, originally written by Gaston Leroux, and converted into a musical by Andrew Lloyd Webber ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... in Webster, Texas have launched a ‘responsive design’ website to inform potential sinus ... to cure them. , The website includes information about a wide variety of ...
(Date:6/30/2015)... Riverside, CA (PRWEB) , ... June 30, 2015 ... ... its position as one of Medicare’s top-rated care centers in the country. To ... Center”, highlighting patient satisfaction and proving its facility is, indeed, worthy of five ...
Breaking Medicine News(10 mins):Health News:1Heart Caregiver Services® Simi Valley Grand Opening 2Health News:1Heart Caregiver Services® Simi Valley Grand Opening 3Health News:1Heart Caregiver Services® Simi Valley Grand Opening 4Health News:HerpesDatingSites.org Introduces a New Responsive Design 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:Villa Health Care Center Announces Highest Care Rating in New Video 2
... of the time childhood acute lymphoblastic leukemia is curable with ... // why it doesn’t work for the other 20 percent ... of a small number of genes that are resistant to ... leukemia cells from 173 children. They looked at the sensitivity ...
... is the leading cause of irreversible vision loss in ... that could be involved with this disease. The discovery ... this disease. ,Researchers collected blood samples from 402 ... was examined for variations in genes that code for ...
... a diet high in fiber from fruit and soy ... -- especially cough with phlegm.// ,Researchers studied ... and more than 44,000 patients without the respiratory problem. ... if certain foods were associated with a reduced risk ...
... help ward off heart disease .Researchers analyzed the role ... thought to play a part in heart disease. ... not find enough evidence in the studies to recommend ... or strokes. Instead, researchers suggest eating a diet rich ...
... risk of bone fractures among kids who take inhaled ... recommend inhaled steroids as the first line of defense ... doctors have long worried these drugs might be weakening ... stems from research showing a link between oral forms ...
... good reason not to smoke. According to a recent study ... increases the risk of having a baby with a cleft ... who were interviewed when their babies were about six months ... during pregnancy, including how many cigarettes she smoked and whether ...
Cached Medicine News:
... low density lipoprotein cholesterol (LDL-C) ... stable, ready-to-use reagent. Selective direct ... Excellent correlation with established reference ... Available with Calibrator: Trucal HDL/LDL ...
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: 3.5 - 7.0 mg/dL. Available with calibrator and number of test 125....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
For the quantitative determination of uric acid in serum....
Medicine Products: